Uitility:
| Study looks at the diagnostic utility of separate detection of Ro52 and Ro60 antibodies. Anti-Ro52 antibodies were found in more diverse patient populations and those with autoimmune disease had a higher risk of inflammatory myositis. Anti-Ro52 antibodies were found 43.1% of the time without Ro60 antibody detection. 24.3% of the time Ro60 antibodies were identified without Ro52 antibodies and in these patients SLE was most common. In 32.6% of the patients both autoantibodies were identified and primary Sjogren's Syndrome was most likely |